BCL2L1 and Werner syndrome: The treatment extracts presented in our investigation exhibited a distinctive suppression of Bcl-xL and Bcl2, which we attribute to the presence of a variety of apoptosis-stimulating functioning metabolites that were previously addressed as being present in WS [44].